An examination of a possible pharmacokinetic interaction between nifedipine and antipyrine
- PMID: 2076727
- DOI: 10.1007/BF00315420
An examination of a possible pharmacokinetic interaction between nifedipine and antipyrine
Abstract
The influence of 2 weeks oral intake of nifedipine (2 x 20 mg) on the oxidative metabolism of antipyrine was investigated in 12 normal volunteers, who had 1050 mg antipyrine solution orally before and after the course of nifedipine. There were no statistically significant differences in the saliva pharmacokinetic parameters of antipyrine on both occassions. However, the metabolite profile of antipyrine in urine showed a significant reduction in the amount of norantipyrine excreted after compared to that before nifedipine administration (16.5 vs 19.6%). This may have implications for drugs that share a similar demethylation pathway with norantipyrine.
Similar articles
-
Antipyrine repeatability and comparison of the powder and capsule formulations.Int J Clin Pharmacol Ther. 1995 Feb;33(2):70-5. Int J Clin Pharmacol Ther. 1995. PMID: 7757313 Clinical Trial.
-
Studies of the different metabolic pathways of antipyrine in man. Oral versus i.v. administration and the influence of urinary collection time.Eur J Clin Pharmacol. 1982;21(5):433-41. doi: 10.1007/BF00542332. Eur J Clin Pharmacol. 1982. PMID: 7075648
-
Influence of renal failure on cytochrome P450 activity in hypertensive patients using a "cocktail" of antipyrine and nifedipine.Eur J Clin Pharmacol. 1996;50(1-2):83-9. doi: 10.1007/s002280050073. Eur J Clin Pharmacol. 1996. PMID: 8739816 Clinical Trial.
-
Lack of pantoprazole drug interactions in man.Int J Clin Pharmacol Ther. 1994 Aug;32(8):385-99. Int J Clin Pharmacol Ther. 1994. PMID: 7981922 Review.
-
Nifedipine: variability in its kinetics and metabolism in man.Pharmacol Ther. 1989;44(3):445-54. doi: 10.1016/0163-7258(89)90010-7. Pharmacol Ther. 1989. PMID: 2519350 Review. No abstract available.
Cited by
-
The potential of the South African plant Tulbaghia Violacea Harv for the treatment of triple negative breast cancer.Sci Rep. 2025 Feb 17;15(1):5737. doi: 10.1038/s41598-025-88417-2. Sci Rep. 2025. PMID: 39962120 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources